![]() |
zurück | ![]() |
Bezeichnung (EINECS und / oder andere) | EC- Nummer | CAS- Nummer | PT01 | PT02 | PT03 | PT04 | PT05 | PT06 | PT07 | PT08 | PT09 | PT10 | PT11 | PT12 | PT13 | PT14 | PT15 | PT16 | PT17 | PT18 | PT19 | PT20 | PT21 | PT22 | PT23 |
Dimethyltetradecyl[3-(trimetho- xysilyl) propyl] ammoniumchlorid | 255-451-8 | 41591-87-1 | 9 | ||||||||||||||||||||||
Gemisch aus cis- und trans-p- Menthan-3,8 diol / Citriodiol | 255-953-7 | 42822-86-6 | 1 | 2 | 19 | ||||||||||||||||||||
4,4-Dimethyloxazolidin | 257-048-2 | 51200-87-4 | 6 | 11 | 12 | 13 | |||||||||||||||||||
Ethyl-N-acetyl-N-butyl-.beta.-alaninat | 257-835-0 | 52304-36-6 | 19 | ||||||||||||||||||||||
.alpha.-Cyan-3- phenoxybenzyl 3- (2,2-dichlorvinyl)-2,2- dimethylcyclo- propancarboxylat / Cypermethrin | 257-842-9 | 52315-07-8 | 8 | 9 | 18 | ||||||||||||||||||||
m-Phenoxybenzyl 3-(2,2-dichlor- vinyl)-2,2-dimethylcyclopropan- carboxylat / Permethrin | 258-067-9 | 52645-53-1 | 2 | 3 | 5 | 8 | 9 | 18 | 19 | 22 | |||||||||||||||
.alpha.-Cyan-3-phenoxybenzyl- [1R-[1.alpha. (S*),3.alpha.]] 3-(2,2-dibromvinyl) -2,2- dimethyl cyclopropan- carboxylat/Deltamethrin | 258-256-6 | 52918-63-5 | 18 | ||||||||||||||||||||||
1-Ethinyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl) cyclopropancarboxylat/Empenthrin | 259-154-4 | 54406-48-3 | 18 | ||||||||||||||||||||||
3-Iod-2-propinyl-butylcarbamat | 259-627-5 | 55406-53-6 | 6 | 7 | 8 | 9 | 10 | 11 | 13 | 18 | |||||||||||||||
Tetrakis(hydroxymethyl) phosphoniumsulfat (2: 1) | 259-709-0 | 55566-30-8 | 2 | 6 | 9 | 11 | 12 | ||||||||||||||||||
3-(3-Biphenyl-4-yl-1,2,3,4-tetra- hydro-1-naphthyl)-4- hydroxycumarin/Difenacoum | 259-978-4 | 56073-07-5 | 14 | ||||||||||||||||||||||
4-Hydroxy-3-(3-(4'-brom-4- biphenylyl)-1,2,3,4-tetrahydro- 1-naphthyl) cumarin/Brodifacoum | 259-980-5 | 56073-10-0 | 14 | ||||||||||||||||||||||
1-[[2-(2,4-Dichlorphenyl)-4-pro- pyl-1,3-dioxolan-2-yl]methyl]- 1H-1,2,4-triazol/Propiconazol | 262-104-4 | 60207-90-1 | 1 | 2 | 4 | 7 | 8 | 9 | 10 | 12 | 13 | 20 | |||||||||||||
4,5-Dichlor-2-octyl- 2H-isothiazol-3-on | 264-843-8 | 64.359-81-5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 21 | |||||||||||||||
2-Chlor-N-[[[4-(trifluormethoxy)- phenyl]amino] carbonyl]benzamid | 264-980-3 | 64628-44-0 | 18 | ||||||||||||||||||||||
3,3'-Methylen-bis[5-methyloxa- zolidin]/Oxazolidin | 266-235-8 | 66204-44-2 | 2 | 6 | 10 | 11 | 12 | 13 | |||||||||||||||||
N-Cyclopropyl-1,3,5-triazin- 2,4,6-triamin | 266-257-8 | 66215-27-8 | 18 | ||||||||||||||||||||||
cis-4-[3-(p-tert-Butylphenyl)-2- methylpropyl]-2,6-dimethyl- morpholin | 266-719-9 | 67564-91-4 | 6 | 7 | 8 | 9 | 10 | 12 | 13 | 21 | |||||||||||||||
.alpha.-Cyan-4-fluor-3-phenoxy- benzyl 3-(2,2-dichlorvinyl)-2,2- dimethyl- cyclopropan- carboxylat/Cyfluthrin | 269-855-7 | 68359-37-5 | 18 |
..
Bezeichnung (EINECS und / oder andere) | EC- Nummer | CAS- Nummer | PT01 | PT02 | PT03 | PT04 | PT05 | PT06 | PT07 | PT08 | PT09 | PT10 | PT11 | PT12 | PT13 | PT14 | PT15 | PT16 | PT17 | PT18 | PT19 | PT20 | PT21 | PT22 | PT23 |
Quaternäre Ammoniumverbindungen, Benzyl-C12-18-alkyldimethyl-, Chloride | 269-919-4 | 68391-01-5 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 9 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 21 | 22 | |||||
Quaternäre Ammoniumverbindungen, Benzyl-C12-16-alkyldimethyl-, Chloride | 270-325-2 | 68.424-85-1 | 1 | 2 | 3 | 4 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | |||||||||||
Quaternäre Ammoniumverbindungen, Di-C8-10-alkyldimethyl, Chloride | 270-331-5 | 68424-95-3 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 9 | 10 | 11 | 12 | 13 | 16 | 22 | |||||||||
Fettsäuren, Kokos-, Reaktions- produkte mit Diethanolamin | 270-430-3 | 68440-04-0 | 3 | ||||||||||||||||||||||
Quaternäre Ammoniumverbindungen, Benzyl-C12-18-alkyldimethyl-, Salze mit 1,2- Benzisothiazol-3(2H)-on-1,1-dioxid (1: 1) | 273-545-7 | 68989-01-5 | 2 | 4 | 11 | 12 | |||||||||||||||||||
Natrium-N-(hydroxymethyl) glycinat | 274-357-8 | 70161-44-3 | 6 | 7 | |||||||||||||||||||||
Amine, C10-16-Alkyldimethyl-, N-Oxide | 274-687-2 | 70592-80-2 | 1 | 2 | |||||||||||||||||||||
Pentakalium- bis(peroxymonosulfat)bis (sulfat) | 274-778-7 | 70693-62-8 | 1 | 2 | 3 | 4 | 5 | 11 | 12 | ||||||||||||||||
N, N'-(Decan-1,10-diyldi-1(4H)- pyridyl-4-yliden)bis (octylammonium) dichlorid | 274-861-8 | 70775-75-6 | 1 | ||||||||||||||||||||||
1,3-Didecyl-2-methyl-1H- imidazoliumchlorid | 274-948-0 | 70862-65-6 | 2 | 3 | 4 | 6 | 7 | 10 | 11 | 12 | 13 | ||||||||||||||
1-[1,3-Bis(hydroxymethyl)-2,5- dioxoimidazolidin-4-yl]-1,3-bis (hydroxymethyl) harnstoff / Diazolidinylurea | 278-928-2 | 78491-02-8 | 6 | 7 | |||||||||||||||||||||
Magnesiummonoperoxyphthalat Hexahydrat | 279-013-0 | 84665-66-7 | 2 | 3 | 4 | ||||||||||||||||||||
Tributyltetradecyl- phosphoniumchlorid | 279-808-2 | 81741-28-8 | 2 | 4 | 9 | 11 | 12 | ||||||||||||||||||
Margosa, Extrakt | 283-644-7 | 84696-25-3 | 18 | 19 | |||||||||||||||||||||
Teersäuren, Polyalkylphenol- Fraktion | 284-893-4 | 84989-05-9 | 2 | 3 | |||||||||||||||||||||
Melaleuca alternifolia, Extrakt / Australisches Teebaumöl | 285-377-1 | 85085-48-9 | 1 | 2 | 3 | 19 |
..
Bezeichnung (EINECS und / oder andere) | EC- Nummer | CAS- Nummer | PT01 | PT02 | PT03 | PT04 | PT05 | PT06 | PT07 | PT08 | PT09 | PT10 | PT11 | PT12 | PT13 | PT14 | PT15 | PT16 | PT17 | PT18 | PT19 | PT20 | PT21 | PT22 | PT23 |
2,4,8,10-Tetra(tert-butyl) -6- hydroxy- 12H-dibenzo[d, g][1,3,2] dioxaphosphocin-6- oxid, Natriumsalz | 286-344-4 | 85209-91-2 | 1 | ||||||||||||||||||||||
Quaternäre Ammoniumverbindungen, Benzyl-C12-14-alkyldi methyl-, Chloride | 287-089-1 | 85409-22-9 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 9 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 21 | 22 | |||||
Quaternäre Ammoniumverbindungen, C12-14-Alkyl[(ethylphenyl) methyl]dimethyl-, Chloride | 287-090-7 | 85409-23-0 | 1 | 2 | 3 | 4 | 5 | 6 | 9 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 21 | 22 | |||||||
.alpha.-Cyan-4-fluor-3- phenoxy- benzyl [1.alpha.(S*),3.alpha.] (±) 3-(2,2-dichlorvinyl) -2,2-dimethyl- cyclopropancarboxylat | 289-244-9 | 86560-93-2 | 18 | ||||||||||||||||||||||
Chrysanthemum cinerariaefolium, Extrakt | 289-699-3 | 89997-63-7 | 18 | 19 | |||||||||||||||||||||
Harnstoff, N,N'-Bis (hydroxymethyl)-, Reaktionsprodukte mit 2-(2-Butoxyethoxy) ethanol, Ethylenglykol und Formaldehyd | 292-348-7 | 90604-54-9 | 2 | 6 | 11 | 12 | 13 | ||||||||||||||||||
Wacholder, Juniperus mexicana, Extrakt | 294-461-7 | 91722-61-1 | 19 | ||||||||||||||||||||||
Lavendel, Lavandula hybrida, Extrakt / Lavandinöl | 294-470-6 | 91722-69-9 | 18 | 19 | |||||||||||||||||||||
Kiefern, Extrakt | 304-455-9 | 94266-48-5 | 10 | ||||||||||||||||||||||
Quaternäre Ammoniumverbindungen, [2-[[2-[(2-Carboxyethyl) (2-hydroxyethyl) amino] ethyl]amino]-2- oxoethyl]- kokosalkyl dimethyl-, Hydroxide, Innere Salze | 309-206-8 | 100085-64-1 | 1 | 2 | 3 | 4 | 6 | 7 | 10 | 11 | 12 | 13 | |||||||||||||
Maiskolben, pulverisiert | 310-127-6 | 999999-99-4 | 14 | ||||||||||||||||||||||
1-(3,5-Dichlor-4-(1,1,2,2-tetra- fluorethoxy)phenyl)-3-(2,6- difluorbenzoyl) harnstoff / Hexaflumuron | 401-400-1 | 86479-06-3 | 18 | ||||||||||||||||||||||
1,3-Dichlor-5-ethyl-5- methylimidazolidin- 2,4-dion | 401-570-7 | 89415-87-2 | 2 | 11 | 12 |
..
Bezeichnung (EINECS und / oder andere) | EC- Nummer | CAS- Nummer | PT01 | PT02 | PT03 | PT04 | PT05 | PT06 | PT07 | PT08 | PT09 | PT10 | PT11 | PT12 | PT13 | PT14 | PT15 | PT16 | PT17 | PT18 | PT19 | PT20 | PT21 | PT22 | PT23 |
1-(4-Chlorphenyl)-4,4-dimethyl- 3-(1,2,4-triazol-1-ylmethyl) pen- tan-3-ol / Tebuconazol | 403-640-2 | 107534-96-3 | 7 | 8 | 9 | 10 | |||||||||||||||||||
Reaktionsprodukte aus: Glutaminsäure und N-(C12-14-alkyl)propylendiamin | 403-950-8 | 164.907-72-6 | 1 | 2 | 3 | 4 | |||||||||||||||||||
Gemisch aus: (C8-18)Alkylbis(2-hydroxyethyl) ammoniumbis(2-ethylhexyl)phosphat; (C8-18)Alkylbis(2-hydroxyethyl) ammonium-2-ethylhexylhydrogenphosphat | 404-690-8 | 68.132-19-4 | 6 | 7 | 9 | ||||||||||||||||||||
2,3,5,6-Tetrafluorbenzyl-trans-2- (2,2-dichlorvinyl) -3,3-dimethyl cyclopropancarboxylat / Transfluthrin | 405-060-5 | 118712-89-3 | 18 | ||||||||||||||||||||||
5,5- Dimethylperhydro- pyrimidin-2-on-.alpha.- (4-trifluor- methylstyryl)-.alpha.-(4-trifluormethyl) cinnamylidenhydrazon / Hydramethylnon | 405-090-9 | 67485-29-4 | 18 | ||||||||||||||||||||||
3-Phenoxybenzyl-2-(4-ethoxy- phenyl) -2-methylpropylether / Etofenprox | 407-980-2 | 80844-07-1 | 2 | 3 | 8 | 18 | |||||||||||||||||||
6-(Phthalimid) peroxyhexansäure | 410-850-8 | 128275-31-0 | 1 | 2 | 3 | 4 | 11 | 12 | |||||||||||||||||
Methylneodecanamid | 414-460-9 | 105726-67-8 | 19 | ||||||||||||||||||||||
Gemisch aus: .alpha.-Cyan-3-phenoxybenzyl -(Z)-(1R,3R)-[(S) 3-(2-chlor-3,3,3-trifluorprop-1- enyl)] -2,2-dimethylcyclo- propancarboxylat; .alpha.-Cyan-3- phenoxybenzyl- (Z)-(1S,3S)-[(R)-3- (2-chlor-3,3,3-trifluorprop-1-enyl)] 2,2-dimethyl- cyclopropan- carboxylat/Lambda Cyhalothrin | 415-130-7 | 91465-08-6 | 18 | ||||||||||||||||||||||
1-(4-(2-Chlor-.alpha., alpha.,.alpha. -p-trifluortolyloxy)-2- fluorphenyl)-3- (2,6-difluorben- zolyl)harnstoff / Flufenoxuron | 417-680-3 | 101463-69-8 | 8 | 18 |
![]() |
weiter . | ![]() |
(Stand: 25.06.2019)
Alle vollständigen Texte in der aktuellen Fassung im Jahresabonnement
Nutzungsgebühr: 90.- € netto (Grundlizenz)
(derzeit ca. 7200 Titel s.Übersicht - keine Unterteilung in Fachbereiche)
Die Zugangskennung wird kurzfristig übermittelt
? Fragen ?
Abonnentenzugang/Volltextversion
...
X
⍂
↑
↓